Showing results (301-310 of 326) with videos related to

Sort By:
Pageof 33
Science (New York, N.Y.)|April 25, 1997
Activation of auditory cortex during silent lipreadingG A Calvert, E T Bullmore, M J Brammer, et al.
British Journal of Pharmacology|November 1, 1990
The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptorM D Tricklebank, T Honoré, S D Iversen, et al.
Journal of the Neurological Sciences|November 1, 1991
Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseasesA V Cheng, I N Ferrier, C M Morris, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 2015
Survival outcomes in elderly patients with glioblastomaD S Tsang, L Khan, J R Perry, et al.
Technology in Cancer Research & Treatment|December 21, 2011
Impact of dose hot spots on spinal cord tolerance following stereotactic body radiotherapy: a generalized biological effective dose analysisA Sahgal, L Ma, J Fowler, et al.
Molecular Pharmacology|November 1, 1994
Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivoS Patel, A J Smith, K L Chapman, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Patterns of practice in the prescription of palliative radiotherapy for the treatment of bone metastases at the Rapid Response Radiotherapy Program between 2005 and 2012N Thavarajah, L Zhang, K Wong, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1990
Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedativeL Singh, A E Donald, A C Foster, et al.
Current Oncology (Toronto, Ont.)|June 6, 2013
Continued success in providing timely palliative radiation therapy at the Rapid Response Radiotherapy Program: a review of 2008-2012N Thavarajah, K Wong, L Zhang, et al.
Journal of Clinical Pathology|November 1, 1994
Bilirubin, ferritin, D-dimers and erythrophages in the cerebrospinal fluid of patients with suspected subarachnoid haemorrhage but negative computed tomography scansK B Page, S J Howell, C M Smith, et al.
Pageof 33